Chambers USA 2018, Client Quote

Whether you’re a cutting-edge medical device startup or a global biopharma leader, it’s mission that drives you. Amid pricing and payor pressures, regulatory scrutiny, emerging innovations and challenging pipelines, market demand continues to grow. To broaden your field of vision as you navigate this dynamic industry, you need integrated, global counsel that can help clear your path to success.

Show More


  • Eli Lilly and Company (NYSE: LLY) with multiple transactions, including the acquisitions of Pacific Biotech Inc. for $135 million and Devices for Vascular Intervention Inc. for $120 million
  • TOLMAR Inc., with a complete defense victory, in an ANDA case in the US District Court for the District of Delaware, where TOLMAR was first to file an ANDA for a generic calcipotriene cream product for the treatment of psoriasis and as a result of the process the plaintiff voluntarily dismissed its case allowing TOLMAR to immediately bring to market its generic product.
  • Amgen Inc., the world’s largest biotech company, with securing a motion to dismiss before the US Court of Appeals for the Third Circuit in a high stakes, class action antitrust case brought by Warren General Hospital, alleging that Amgen had illegally tied sales of its blockbuster drugs, Neulasta® and Neupogen®, with another of its drugs

Show More


McDermott’s Life Sciences Team will get you closer to your goals. Composed of top lawyers with demonstrated strength across intellectual property, regulatory, transactional and litigation law, we’re a purpose-built team of thought leaders united by a passion for our work.